Livedoid vasculitis - 青斑樣血管炎 https://en.wikipedia.org/wiki/Livedoid_vasculitis
https://en.wikipedia.org/wiki/Livedoid_vasculitis
☆ AI Dermatology — Free Service德國 Stiftung Warentest 2022 年的結果顯示,消費者對 ModelDerm 的滿意度僅略低於付費遠距醫療諮詢。   - 可能會伴隨疼痛。 
relevance score : -100.0%
References Livedoid vasculopathy: A review with focus on terminology and pathogenesis 36285834
 Livedoid vasculopathy: A review with focus on terminology and pathogenesis 36285834 NIH
Livedoid vasculopathy 是一種罕見的皮膚疾病,其特徵為小腿上持續出現疼痛性潰瘍。
Livedoid vasculopathy (LV) is a rare thrombotic vasculopathy of the dermis characterized by painful, relapsing ulcers over the lower extremities. Diagnosis is challenging due to the overlap in clinical appearance and nomenclature with other skin disorders. Treatment selection is complicated by poor understanding of the pathogenesis of LV and lack of robust clinical trials evaluating therapy efficacy. The terminology and pathophysiology of LV are reviewed here, along with its epidemiology, clinical and histologic features, and treatment options. A diagnostic pathway is suggested to guide providers in evaluating for comorbidities, referring to appropriate specialists, and choosing from the available classes of therapy.
 Livedoid vasculopathy: A review of pathogenesis and principles of management 27297279
 Livedoid vasculopathy: A review of pathogenesis and principles of management 27297279Livedoid vasculopathy 是一種罕見的皮膚病,會導致小腿反覆出現潰瘍,留下白色疤痕,稱為白色萎縮。雖然確切原因尚不清楚,但據信凝血增加 (hypercoagulability) 是主要因素,發炎則為次要因素。導致凝血的因素包括:蛋白C、蛋白S 缺乏;遺傳突變如 factor V Leiden;抗凝血酶III 缺乏;凝血酶原基因突變;以及同型半胱氨酸水平升高。組織切片顯示血管內有血栓、血管壁增厚及疤痕。治療需多管齊下,重點是使用抗血小板藥物、抗凝劑與纖溶療法等藥物來預防血栓。可使用的藥物包括 colchicine、hydroxychloroquine、血管擴張劑以及免疫抑制劑等。
Livedoid vasculopathy is a rare skin condition that causes recurring ulcers on the lower legs, leaving behind pale scars known as atrophie blanche. While the exact cause is still unclear, it's believed that increased blood clotting (hypercoagulability) is the main factor, with inflammation playing a secondary role. Factors contributing to clotting include as follows - deficiencies in proteins C and S, genetic mutations like factor V Leiden, antithrombin III deficiency, prothrombin gene mutations, high levels of homocysteine. In biopsies, the condition shows blood clots inside vessels, thickening of vessel walls, and scarring. Treatment involves a multi-pronged approach focusing on preventing blood clots with medications like anti-platelet drugs, blood thinners, and fibrinolytic therapy. Various drugs can be used for this skin condition - colchicine and hydroxychloroquine, vasodilators, immunosuppressants.
 Livedoid Vasculopathy 32644463
 Livedoid Vasculopathy 32644463 NIH
Livedoid vasculopathy 是一種罕見的疾病,常累及雙腿。微小血管中血栓的形成被認為是由凝血增加、血栓分解減少以及血管內壁損傷所致。此病在女性中較常見,尤其是 15 歲至 50 歲之間的患者。
Livedoid vasculopathy is a rare vasculopathy that is typically characterized by bilateral lower limb lesions. Increased thrombotic activity and decreased fibrinolytic activity along with endothelial damage are believed to be the cause of thrombus formation in the capillary vasculature. It is 3 times more common in females than in males, especially in patients between the ages of 15 to 50 years. There is no definite first-line treatment, but general measures like smoking cessation, wound care, and pharmacological measures like anticoagulants and antiplatelets have shown good results.